Fig. 1From: Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19Levels of syndecan-1 and thrombomodulin in survivors and non-survivors COVID-19 patients. A The levels of syndecan-1 were significantly higher in non-survivor group compared with survivor group. B The levels of thrombomodulin were not significantly different between non-survivor group and survivor groupBack to article page